1. Reciprocal regulation of activating and inhibitory Fc{gamma} receptors by TLR7/8 activation: implications for tumor immunotherapy.
- Author
-
Butchar JP, Mehta P, Justiniano SE, Guenterberg KD, Kondadasula SV, Mo X, Chemudupati M, Kanneganti TD, Amer A, Muthusamy N, Jarjoura D, Marsh CB, Carson WE 3rd, Byrd JC, and Tridandapani S
- Subjects
- Animals, Antibody-Dependent Cell Cytotoxicity drug effects, Antibody-Dependent Cell Cytotoxicity immunology, Antineoplastic Agents pharmacology, Antineoplastic Agents therapeutic use, Cytokines immunology, Cytokines metabolism, Humans, Imidazoles pharmacology, Imidazoles therapeutic use, Immunologic Factors pharmacology, Immunologic Factors therapeutic use, Macrophages drug effects, Macrophages immunology, Macrophages metabolism, Mice, Mice, Inbred C57BL, Mice, Knockout, Neoplasms immunology, Neoplasms metabolism, Receptors, IgG immunology, Receptors, IgG physiology, Toll-Like Receptor 7 metabolism, Toll-Like Receptor 8 metabolism, Tumor Cells, Cultured, Immunotherapy methods, Neoplasms therapy, Receptors, IgG metabolism, Toll-Like Receptor 7 agonists, Toll-Like Receptor 8 agonists
- Abstract
Purpose: Activation of Toll-like receptors (TLR) 7 and 8 by engineered agonists has been shown to aid in combating viruses and tumors. Here, we wished to test the effect of TLR7/8 activation on monocyte Fcgamma receptor (FcgammaR) function, as they are critical mediators of antibody therapy., Experimental Design: The effect of the TLR7/8 agonist R-848 on cytokine production and antibody-dependent cellular cytotoxicity by human peripheral blood monocytes was tested. Affymetrix microarrays were done to examine genomewide transcriptional responses of monocytes to R-848 and Western blots were done to measure protein levels of FcgammaR. Murine bone marrow-derived macrophages from WT and knockout mice were examined to determine the downstream pathway involved with regulating FcgammaR expression. The efficacy of R-848 as an adjuvant for antibody therapy was tested using a CT26-HER2/neu solid tumor model., Results: Overnight incubation with R-848 increased FcgammaR-mediated cytokine production and antibody-dependent cellular cytotoxicity in human peripheral blood monocytes. Expression of FcgammaRI, FcgammaRIIa, and the common gamma-subunit was increased. Surprisingly, expression of the inhibitory FcgammaRIIb was almost completely abolished. In bone marrow-derived macrophage, this required TLR7 and MyD88, as R-848 did not increase expression of the gamma-subunit in TLR7(-/-) nor MyD88(-/-) cells. In a mouse solid tumor model, R-848 treatment superadditively enhanced the effects of antitumor antibody., Conclusions: These results show an as-yet-undiscovered regulatory and functional link between the TLR7/8 and FcgammaR pathways. This suggests that TLR7/8 agonists may be especially beneficial during antibody therapy., (Copyright 2010 AACR.)
- Published
- 2010
- Full Text
- View/download PDF